Oxidant/antioxidant balance in patients with thyroid cancer

Akinci, Melih; Kosova, Funda; Çetin, Bahadir; Sepici, Aylin; Altan, Nilgün; Aslan, Sebahattin; Çetin, Abdullah.
Acta cir. bras ; 23(6): 551-554, Nov.-Dec. 2008. tab
Artículo en Inglés | LILACS | ID: lil-496759

Documentos relacionados

  1. High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma.
  2. Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid Cancer.
  3. Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer.
  4. Notch Signaling in Thyroid Cancer.
  5. Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.
  6. CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.
  7. [Therapy concepts for thyroid carcinoma].
  8. Selenium and thyroid cancer: a systematic review.
  9. Clinical use of thyroglobulin: not only thyroid cancer.
  10. Promising Role of Alkaloids in the Prevention and Treatment of Thyroid Cancer and Autoimmune Thyroid Disease: A Comprehensive Review of the Current Evidence.